Drug Profile
Research programme: steroid-protein conjugates - Medexis
Alternative Names: CastBSA project; MED-C100; Steroid-protein conjugates research programme - MedexisLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Medexis
- Class Albumins; Drug conjugates; Small molecules; Steroids
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Prostate cancer
Most Recent Events
- 04 Feb 2011 No development reported - Preclinical for Cancer in Greece (unspecified route)
- 04 Feb 2011 No development reported - Preclinical for Prostate cancer in Greece (unspecified route)
- 07 May 2010 Pharmacodynamics data from a preclinical study in prostate cancer presented at the 101st Annual Meeting of the American Association for Cancer Research